Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Townsend

Showing results (81-90 of 138) with videos related to

Pageof 14
Sort By:
Journal of Medicinal Chemistry|February 28, 1997
Synthesis and evaluation of 6-(dibromomethyl)-5-nitropyrimidines as potential antitumor agentsM D Thompson, T L Cupps, D S Wise, et al.
Journal of Medicinal Chemistry|October 1, 1981
Pyrazolopyrimidine nucleosides. 12. Synthesis and biological activity of certain pyrazolo[3,4-d]pyrimidine nucleosides related to adenosineG A Bhat, J L Montero, R P Panzica, et al.
Cancer Treatment Reports|April 1, 1986
Mechanism of activation of triciribine phosphate (TCN-P) as a prodrug form of TCNL L Wotring, G W Crabtree, N L Edwards, et al.
The Journal of Organic Chemistry|March 1, 1970
Purine nucleosides. XXVI. A general synthesis of 6-substituted 9-(beta-D-ribofuranosyl) purines. A reinvestigation and corroboration of the position of glycosylation of 6-dimethylamino-"7"-(beta-D-ribofuranosyl) purineR J Rousseau, R P Panzica, S M Reddick, et al.
Journal of Medicinal Chemistry|May 9, 1998
Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazoleA R Porcari, R V Devivar, L S Kucera, et al.
Cancer Research|February 1, 1986
Potentiation of 2'-deoxyguanosine cytotoxicity by a novel inhibitor of purine nucleoside phosphorylase, 8-amino-9-benzylguanineD S Shewach, J W Chern, K E Pillote, et al.
Journal of Medicinal Chemistry|September 29, 1995
Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-D-ribofuranosyl)benzimidazolesL B Townsend, R V Devivar, S R Turk, et al.
Journal of the American Chemical Society|December 20, 2011
Correction. X--ray and (1)H NMR Analyses of the Structure and Conformation of 2-Azacoformycin, a Potent Inhibitor or Adenosine DeaminaseG I Birnbaum, J R Brisson, S H Krawczyk, et al.
Cancer Research|December 1, 1985
Effects of the tricyclic nucleoside 6-amino-4-methyl-8-(beta-D-ribofuranosyl)- pyrrolo[4,3,2-de]pyrimido[4,5-c]pyridazine on the viability and cell cycle distribution of L1210 cells in vitroL L Wotring, J E Passiatore, J L Roti Roti, et al.
Biochimica Et Biophysica Acta|December 7, 1973
Formation of 3,5,5-trimethyl derivatives of dihydrouracil nucleosides by reaction with methylsulfinyl carbanion and methyl iodideR P Panzica, L B Townsend, D L Von Minden, et al.
Pageof 14

Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
Journal of Medicinal Chemistry|February 28, 1997
Synthesis and evaluation of 6-(dibromomethyl)-5-nitropyrimidines as potential antitumor agentsM D Thompson, T L Cupps, D S Wise, et al.
Journal of Medicinal Chemistry|October 1, 1981
Pyrazolopyrimidine nucleosides. 12. Synthesis and biological activity of certain pyrazolo[3,4-d]pyrimidine nucleosides related to adenosineG A Bhat, J L Montero, R P Panzica, et al.
Cancer Treatment Reports|April 1, 1986
Mechanism of activation of triciribine phosphate (TCN-P) as a prodrug form of TCNL L Wotring, G W Crabtree, N L Edwards, et al.
The Journal of Organic Chemistry|March 1, 1970
Purine nucleosides. XXVI. A general synthesis of 6-substituted 9-(beta-D-ribofuranosyl) purines. A reinvestigation and corroboration of the position of glycosylation of 6-dimethylamino-"7"-(beta-D-ribofuranosyl) purineR J Rousseau, R P Panzica, S M Reddick, et al.
Journal of Medicinal Chemistry|May 9, 1998
Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazoleA R Porcari, R V Devivar, L S Kucera, et al.
Cancer Research|February 1, 1986
Potentiation of 2'-deoxyguanosine cytotoxicity by a novel inhibitor of purine nucleoside phosphorylase, 8-amino-9-benzylguanineD S Shewach, J W Chern, K E Pillote, et al.
Journal of Medicinal Chemistry|September 29, 1995
Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-D-ribofuranosyl)benzimidazolesL B Townsend, R V Devivar, S R Turk, et al.
Journal of the American Chemical Society|December 20, 2011
Correction. X--ray and (1)H NMR Analyses of the Structure and Conformation of 2-Azacoformycin, a Potent Inhibitor or Adenosine DeaminaseG I Birnbaum, J R Brisson, S H Krawczyk, et al.
Cancer Research|December 1, 1985
Effects of the tricyclic nucleoside 6-amino-4-methyl-8-(beta-D-ribofuranosyl)- pyrrolo[4,3,2-de]pyrimido[4,5-c]pyridazine on the viability and cell cycle distribution of L1210 cells in vitroL L Wotring, J E Passiatore, J L Roti Roti, et al.
Biochimica Et Biophysica Acta|December 7, 1973
Formation of 3,5,5-trimethyl derivatives of dihydrouracil nucleosides by reaction with methylsulfinyl carbanion and methyl iodideR P Panzica, L B Townsend, D L Von Minden, et al.
Pageof 14